跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule
Approved
STANDARD
Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule
Bridgewest Perth Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f24bb79942d25a3c
Company
Bridgewest Perth Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
f24bb79942d25a3c
Product Name
Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule
Artg Id
49293
Artg Name
Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule
Sponsor
Bridgewest Perth Pharma Pty Ltd
Company Detail Path
/organization/bridgewest-perth-pharma-pty-ltd
Artg Date
1994-06-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ea98b2fe1e0591373088456f835dbb65.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c0ff7ed66aedb90e8ba12acd0af18704.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f24bb79942d25a3c
Type
Standard
Back to TGA Approvals